bibliographicCitation |
Yamamoto T, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1996 Feb;40(2):426–8. PMID: 8834891; PMCID: PMC163127. |